Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? - Test2 - elhamkhani - TriplyDB

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

http://www.wikidata.org/entity/Q38003648

about

Role of insulin in the type 2 diabetes therapy: past, present and future

P2860

Q22241148-433DB3C1-76EB-432F-BBD3-0E90C7E53FA5

P2860

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

http://www.wikidata.org/entity/Q38003648

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

@en

type

label

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

@en

prefLabel

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

@en

P1433

Q38003648-D2158D7C-6403-468F-B33C-E6C9C48FCBC2

P1476

Q38003648-F69488E6-EE44-4ED5-B0EB-1746CB7FF63E

P2860

Q38003648-111AB795-B10B-4DA1-A52A-34A0101B66A5

Q38003648-12DF6116-C23F-41EC-B474-400508721AEA

Q38003648-2FB6C72D-DE15-4FE4-9905-093E5478EFD6

Q38003648-34EFFDA2-8E0B-4A9E-8E91-352DD544F066

Q38003648-43FAF748-D996-4B5B-B075-BEB60BF40AA9

Q38003648-47B7D9AB-79F4-4741-962B-ECEB5048466E

Q38003648-676F88EA-E1CB-47B2-A1EB-5AEDACCD0859

Q38003648-6C3637FA-1021-4981-AEE7-3BB46D5A40F8

Q38003648-6C540339-7163-488D-ADE3-2BBD3B0E9AF6

Q38003648-6D8EAB89-D9ED-4F8E-A93F-2637BD8E20D6

P304

Q38003648-69AE99E1-9E2C-4F38-99DE-C8EEB89406F6

P31

Q38003648-08A41C42-F324-44CC-900E-4FE726AEEFEB

P356

Q38003648-8E5DBA53-6F73-43A3-A16C-F4804BE7ABEE

P407

Q38003648-B0052F55-D0B0-4A45-A883-943AB2020F40

P433

Q38003648-4A5B63E2-EF14-4F7E-8372-BC9AC084EB66

P478

Q38003648-DB1F2A5B-4A47-4652-8E99-3DE4F9F74EC9

P50

Q38003648-6E3F885B-5F10-4BB0-A31A-C16E2C08119A

Q38003648-CF0AF92B-58F2-4D92-9A62-3DF8B843710F

Q38003648-E221A04E-E115-4F05-9295-E9A4BCCAC406

P577

Q38003648-6C401DD9-47A1-4A5D-9C82-0F05E93843FE

P698

Q38003648-3E256A5A-F26B-49B6-91B8-2EFA1B2E76A4

P921

Q38003648-6FDCDEA8-981C-433A-98E4-2F6A08997594

P356

14712598.2012.675324

P1433

Expert Opinion on Biological Therapy

P1476

Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

@en

P2860

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Impaired fasting glucose and impaired glucose tolerance: implications for care

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?

Oral insulin and buccal insulin: a critical reappraisal.

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach.

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance.

Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.

Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.

Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.

P304

767-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2012.675324

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ernesto Maddaloni

P577

2012-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22515262

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes